Delta Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $351K | Buy |
788
+106
| +16% | +$47.2K | 0.12% | 95 |
|
|
2025
Q1 | $331K | Buy |
682
+31
| +5% | +$15K | 0.12% | 96 |
|
|
2024
Q4 | $262K | Buy |
651
+13
| +2% | +$5.24K | 0.1% | 104 |
|
|
2024
Q3 | $297K | Buy |
638
+20
| +3% | +$9.3K | 0.11% | 101 |
|
|
2024
Q2 | $290K | Hold |
618
| – | – | 0.11% | 100 |
|
|
2024
Q1 | $258K | Buy |
618
+15
| +2% | +$6.27K | 0.1% | 103 |
|
|
2023
Q4 | $245K | Hold |
603
| – | – | 0.11% | 109 |
|
|
2023
Q3 | $210K | Hold |
603
| – | – | 0.09% | 120 |
|
|
2023
Q2 | $212K | Buy |
+603
| New | +$212K | 0.09% | 117 |
|